AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Inhibition of post-ischemic brain injury by clusterin overexpression
Authors: Holtzman, DM Han, BH He, YY Kim, GM Choi, JJ Hsu, C
Citation: Dm. Holtzman et al., Inhibition of post-ischemic brain injury by clusterin overexpression, NAT MED, 7(9), 2001, pp. 977-979
Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia
Authors: Han, BH DeMattos, RB Dugan, LL Kim-Han, JS Brendza, RP Fryer, JD Kierson, M Cirrito, J Quick, K Harmony, JAK Aronow, BJ Holtzman, DM
Citation: Bh. Han et al., Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia, NAT MED, 7(3), 2001, pp. 338-343
BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: Evidence for distinct apoptosis pathways
Authors: Gibson, ME Han, BH Choi, JJ Knudson, CM Korsmeyer, SJ Parsadanian, M Holtzman, DM
Citation: Me. Gibson et al., BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: Evidence for distinct apoptosis pathways, MOL MED, 7(9), 2001, pp. 644-655
Role of apoE/A beta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy
Authors: Holtzman, DM
Citation: Dm. Holtzman, Role of apoE/A beta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy, J MOL NEURO, 17(2), 2001, pp. 147-155
Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice
Authors: DeMattos, RB Brendza, RP Heuser, JE Kierson, M Cirrito, JR Fryer, J Sullivan, PM Fagan, AM Han, XL Holtzman, DM
Citation: Rb. Demattos et al., Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice, NEUROCHEM I, 39(5-6), 2001, pp. 415-425
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance anddecreases brain A beta burden in a mouse model of Alzheimer's disease
Authors: DeMattos, RB Bales, KR Cummins, DJ Dodart, JC Paul, SM Holtzman, DM
Citation: Rb. Demattos et al., Peripheral anti-A beta antibody alters CNS and plasma A beta clearance anddecreases brain A beta burden in a mouse model of Alzheimer's disease, P NAS US, 98(15), 2001, pp. 8850-8855
Plasmalogen deficiency in early Alzheimer's disease subjects and in animalmodels: molecular characterization using electrospray ionization mass spectrometry
Authors: Han, XL Holtzman, DM McKeel, DW
Citation: Xl. Han et al., Plasmalogen deficiency in early Alzheimer's disease subjects and in animalmodels: molecular characterization using electrospray ionization mass spectrometry, J NEUROCHEM, 77(4), 2001, pp. 1168-1180
Role of nerve growth factor in experimental autoimmune encephalomyelitis
Authors: Arredondo, LR Deng, CS Ratts, RB Lovett-Racke, AE Holtzman, DM Racke, MK
Citation: Lr. Arredondo et al., Role of nerve growth factor in experimental autoimmune encephalomyelitis, EUR J IMMUN, 31(2), 2001, pp. 625-633
Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo
Authors: Fagan, AM Holtzman, DM
Citation: Am. Fagan et Dm. Holtzman, Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo, MICROSC RES, 50(4), 2000, pp. 297-304
BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
Authors: Han, BH D'Costa, A Back, SA Parsadanian, M Patel, S Shah, AR Gidday, JM Srinivasan, A Deshmukh, M Holtzman, DM
Citation: Bh. Han et al., BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia, NEUROBIOL D, 7(1), 2000, pp. 38-53
No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo
Authors: Lendon, CL Han, BH Salimi, K Fagan, AM Behrens, MI Muller, MC Holtzman, DM
Citation: Cl. Lendon et al., No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo, EUR J NEURO, 12(7), 2000, pp. 2235-2242
Differences in the A beta 40/A beta 42 ratio associated with cerebrospinalfluid lipoproteins as a function of apolipoprotein E genotype
Authors: Fagan, AM Younkin, LH Morris, JC Fryer, JD Cole, TG Younkin, SG Holtzman, DM
Citation: Am. Fagan et al., Differences in the A beta 40/A beta 42 ratio associated with cerebrospinalfluid lipoproteins as a function of apolipoprotein E genotype, ANN NEUROL, 48(2), 2000, pp. 201-210
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formationin an Alzheimer's disease model
Authors: Holtzman, DM Fagan, AM Mackey, B Tenkova, T Sartorius, L Paul, SM Bales, K Ashe, KH Irizarry, MC Hyman, BT
Citation: Dm. Holtzman et al., Apolipoprotein E facilitates neuritic and cerebrovascular plaque formationin an Alzheimer's disease model, ANN NEUROL, 47(6), 2000, pp. 739-747
Role of tissue plasminogen activator receptor LRP in hippocampal long-termpotentiation
Authors: Zhuo, M Holtzman, DM Li, YH Osaka, H DeMaro, J Jacquin, M Bu, GJ
Citation: M. Zhuo et al., Role of tissue plasminogen activator receptor LRP in hippocampal long-termpotentiation, J NEUROSC, 20(2), 2000, pp. 542-549
Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice
Authors: Ho, N Liauw, JA Blaeser, F Wei, F Hanissian, S Muglia, LM Wozniak, DF Nardi, A Arvin, KL Holtzman, DM Linden, DJ Zhuo, M Muglia, LJ Chatila, TA
Citation: N. Ho et al., Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice, J NEUROSC, 20(17), 2000, pp. 6459-6472
BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
Authors: Han, BH Holtzman, DM
Citation: Bh. Han et Dm. Holtzman, BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway, J NEUROSC, 20(15), 2000, pp. 5775-5781
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
Authors: Holtzman, DM Bales, KR Tenkova, T Fagan, AM Parsadanian, M Sartorius, LJ Mackey, B Olney, J McKeel, D Wozniak, D Paul, SM
Citation: Dm. Holtzman et al., Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease, P NAS US, 97(6), 2000, pp. 2892-2897
Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
Authors: Shibata, M Yamada, S Kumar, SR Calero, M Bading, J Frangione, B Holtzman, DM Miller, CA Strickland, DK Ghiso, J Zlokovic, BV
Citation: M. Shibata et al., Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier, J CLIN INV, 106(12), 2000, pp. 1489-1499
Behavioral phenotyping of GFAP-ApoE3 and-ApoE4 transgenic mice: ApoE4 miceshow profound working memory impairments in the absence of Alzheimer's-like neuropathology
Authors: Hartman, RE Wozniak, DF Nardi, A Olney, JW Sartorius, L Holtzman, DM
Citation: Re. Hartman et al., Behavioral phenotyping of GFAP-ApoE3 and-ApoE4 transgenic mice: ApoE4 miceshow profound working memory impairments in the absence of Alzheimer's-like neuropathology, EXP NEUROL, 170(2), 2000, pp. 326-344
BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia
Authors: Almli, CR Levy, TJ Han, BH Shah, AR Gidday, JM Holtzman, DM
Citation: Cr. Almli et al., BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia, EXP NEUROL, 166(1), 2000, pp. 99-114
Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning
Authors: Gidday, JM Shah, AR Maceren, RG Wang, QO Pelligrino, DA Holtzman, DM Park, TS
Citation: Jm. Gidday et al., Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning, J CEREBR B, 19(3), 1999, pp. 331-340
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: New insights into mechanism of beta-sheet formation
Authors: Kowalewski, T Holtzman, DM
Citation: T. Kowalewski et Dm. Holtzman, In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: New insights into mechanism of beta-sheet formation, P NAS US, 96(7), 1999, pp. 3688-3693
In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
Authors: Selznick, LA Holtzman, DM Han, BH Gokden, M Srinivasan, AN Johnson, EM Roth, KA
Citation: La. Selznick et al., In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease, J NE EXP NE, 58(9), 1999, pp. 1020-1026
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease
Authors: Holtzman, DM Bales, KR Wu, S Bhat, P Parsadanian, M Fagan, AM Chang, LK Sun, YL Paul, SM
Citation: Dm. Holtzman et al., Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease, J CLIN INV, 103(6), 1999, pp. R15-R21
Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice
Authors: Fagan, AM Holtzman, DM Munson, G Mathur, T Schneider, D Chang, LK Getz, GS Reardon, CA Lukens, J Shah, JA LaDu, MJ
Citation: Am. Fagan et al., Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice, J BIOL CHEM, 274(42), 1999, pp. 30001-30007
Risultati: 1-25 | 26-27